BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23618918)

  • 1. Met/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes.
    Nakayama M; Sakai K; Yamashita A; Nakamura T; Suzuki Y; Matsumoto K
    Cytokine; 2013 Jun; 62(3):446-52. PubMed ID: 23618918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z; Mizuno S; Nakamura T
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
    Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
    Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
    Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
    Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
    Corpechot C; Barbu V; Wendum D; Chignard N; Housset C; Poupon R; Rosmorduc O
    Am J Pathol; 2002 Feb; 160(2):613-20. PubMed ID: 11839582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development.
    Ishikawa KS; Masui T; Ishikawa K; Shiojiri N
    Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase.
    Machide M; Hashigasako A; Matsumoto K; Nakamura T
    J Biol Chem; 2006 Mar; 281(13):8765-72. PubMed ID: 16415345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
    Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
    Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice.
    Hsu YC; Huang HP; Yu IS; Su KY; Lin SR; Lin WC; Wu HL; Shi GY; Tao MH; Kao CH; Wu YM; Martin PE; Lin SY; Yang PC; Lin SW
    Hepatology; 2012 Nov; 56(5):1913-23. PubMed ID: 22505209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats.
    Hasuike S; Ido A; Uto H; Moriuchi A; Tahara Y; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1753-61. PubMed ID: 16246197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
    Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP
    Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor.
    Fukuta K; Matsumoto K; Nakamura T
    Biochem J; 2005 Jun; 388(Pt 2):555-62. PubMed ID: 15693751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
    Kim WH; Matsumoto K; Bessho K; Nakamura T
    Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K; Nakamura T; Sakai K; Nakamura T
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C/EBPbeta contributes to hepatocyte growth factor-induced replication of rodent hepatocytes.
    Wang B; Gao C; Ponder KP
    J Hepatol; 2005 Aug; 43(2):294-302. PubMed ID: 15922473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of phospholipase C gamma in c-met/HGF receptor-stimulated hepatocytes: comparison with HepG2 hepatocarcinoma cells.
    Okano Y; Mizuno K; Osada S; Nakamura T; Nozawa Y
    Biochem Biophys Res Commun; 1993 Feb; 190(3):842-8. PubMed ID: 7679901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor stimulates the induction of cytokine-induced neutrophil chemoattractant through the activation of NF-kappaB in rat hepatocytes.
    Kaibori M; Yanagida H; Nakanishi H; Ozaki T; Yoshida H; Matsui K; Hijikawa T; Kamiyama Y; Okumura T
    J Surg Res; 2006 Jan; 130(1):88-93. PubMed ID: 16271365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dephosphorylated Ser985 of c-Met is associated with acquired resistance to rechallenge injury in rats that had recovered from uranyl acetate-induced subclinical renal damage.
    Fujikura T; Togawa A; Sun Y; Iwakura T; Yasuda H; Fujigaki Y
    Clin Exp Nephrol; 2013 Aug; 17(4):504-14. PubMed ID: 23250664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.